+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Pipeline Review of Rheumatoid Arthritis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pre Book Price: $ 5216

Original Price: $ 5795

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. The cause of rheumatoid arthritis is not known. The joint inflammation of rheumatoid arthritis causes swelling, pain, stiffness and redness in the joints. It can lead to a significant loss of mobility due to pain and joint destruction. The disease is also systematic, i.e. it affect extra articular tissues throughout the body. The disease is three times more common in women as in men.Pharmacological treatment of rheumatoid arthritis can be divided into disease-modifying antirheumatic drugs (DMARDs), anti-inflammatory agents and analgesics. The highly innovative products are expected to increase the diversity of available products. 
Rheumatoid Arthritis - Pipeline Review, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Rheumatoid Arthritis, with latest updates.Some of the players involved in the therapeutic development for Rheumatoid Arthritis are Alcon, Bristol-Myers Squibb Company, Johnson &Johnson, Amgen, Antares Pharma, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Inovio Biomedical Corporation, Isis Pharmaceuticals, Biotest AG, Merck & Co and Santen Pharmaceutical.

Scope
  • The report provides a snapshot of the global Rheumatoid Arthritis Drugs Market.
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the development of Rheumatoid Arthritis Drugs and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • Coverage of the Rheumatoid Arthritis Drugs pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons to buy

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top